SCHEMBL5506656

SCHEMBL5506656

O=C(O)C1(CNc2ccccc2)CCCCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.44
AKR1C1 Q04828 1/20 0.42
CTSK P43235 1/20 0.40
EPHX1 P07099 1/20 0.40
HDAC4 P56524 1/20 0.40
ALDH1A1 P00352 4/20 0.40
LMNA P02545 4/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
USP2 O75604 1/20 0.40
HPGD P15428 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
KDM4E B2RXH2 2/20 0.40
NPC1 O15118 1/20 0.40
POLB P06746 1/20 0.40
MMP1 P03956 1/20 0.39
CETP P11597 1/20 0.39
DPP7 Q9UHL4 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7186992 0.77 ALDH1A1 (0.53) ALDH1A1LMNAUSP2HPGDKMT2A
SCHEMBL1756726 0.77 LMNA (0.63) CTSKALDH1A1LMNAL3MBTL1MEN1
SCHEMBL2241093 0.77 DPP7 (0.42) CYP2C19CTSKALDH1A1LMNAMEN1
SCHEMBL11188794 0.76 KMT2A (0.45) CYP2C19AKR1C1HDAC4LMNAL3MBTL1
SCHEMBL23137098 0.75 CTSK (0.42) CYP2C19CTSKALDH1A1LMNAHPGD
SCHEMBL7497785 0.74 BRD4 (0.46) CYP2C19ALDH1A1LMNAKDM4EMMP1
SCHEMBL4532055 0.73 NPC1 (0.43) CYP2C19ALDH1A1MEN1KMT2ANPC1
SCHEMBL30920015 0.73 KDM4E (0.57) ALDH1A1HPGDMEN1KMT2AKDM4E
SCHEMBL4866845 0.73 NPC1 (0.43) CYP2C19ALDH1A1MEN1KMT2ANPC1
SCHEMBL17234146 0.73 KDM4E (0.57) ALDH1A1HPGDMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1773786-A2 FIVE-MEMBERED HETEROCYCLES USEFUL AS SERINE PROTEASE INHIBITORS Bristol-Myers Squibb Company (US) 2007-04-18 EP disclosed
WO-2005123050-A2 FIVE-MEMBERED HETEROCYCLES USEFUL AS SERINE PROTEASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2005-12-29 WO disclosed